
Esoblis Injection
Marketer
Syndicate Life Sciences Pvt Ltd
Salt Composition
Esomeprazole (40mg)
Overview Esoblis Injection
Gastric acid secretion is inhibited by the intravenous medication, Esoblis Injection. Indicated for managing stomach and intestinal disorders stemming from excessive acid, including acid reflux and other hyperacidity conditions, it also prevents stress ulcers in critically ill patients and is prophylactically administered before anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), Esoblis Injection is administered intravenously by a medical professional only when deemed more appropriate than oral forms by your physician. Dosage and treatment length are individualized based on your condition and response. Optimizing treatment involves consuming smaller, more frequent meals, and limiting caffeine, spicy foods, and high-fat items. Common, generally mild, side effects include injection site reactions, nausea, headache, dizziness, gas, diarrhea, abdominal pain, and fundic gland polyps. Persistent or bothersome side effects warrant medical attention. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Prior to Esoblis Injection, inform your physician of severe hepatic impairment, HIV medication use, prior allergic reactions to similar drugs, or pre-existing osteoporosis. Pregnant or lactating individuals should also seek medical advice. Alcohol consumption, which stimulates gastric acid production, should be avoided to prevent symptom exacerbation.
Primary Ingredients of Esoblis Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Esoblis Injection
Managing Gastroesophageal Reflux Disease (GERD)
Major Benefits of Esoblis Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Esoblis Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Esoblis Injection:
Administering this medication will be handled by your physician or their qualified assistant; please refrain from self-medicating.
How Esoblis Injection works:
Gastric acid secretion is decreased by Esoblis Injection, a proton pump inhibitor, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Esoblis Injection with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Esoblis Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Esoblis Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Esoblis Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Caution is advised when administering Esoblis Injection to individuals with severe kidney impairment; dosage modification may be necessary. A physician's consultation is recommended. Dosage alteration is unnecessary for patients exhibiting mild or moderate kidney dysfunction.
LiverCAUTION
Caution is advised when administering Esoblis Injection to individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Dosage alteration is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Esoblis Injection :
Should you forget a scheduled Esoblis Injection, seek medical advice.
Facts to Know About Esoblis Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
